Acumed and OsteoMed Announce Business Units and Leaders
January 14, 2021
The combined Acumed | OsteoMed organization will be structured into Business Units whose leaders will be responsible for global sales, marketing, and research and development.
In October 2020, Colson Medical, LLC—part of Marmon Holdings, Inc., a Berkshire Hathaway company—announced the merger of Acumed and OsteoMed. The combined organization will be structured into Business Units (BU) whose leaders will be responsible for global sales, marketing, and research and development.
“Our business unit leaders will deliver our combined mission, vision, and values,” said Sharon Wolfington, President and CEO of Acumed | OsteoMed. “Our patient-centric culture and mission will continue to drive our combined organizations to deliver comprehensive solutions to assist our customers in achieving optimal restoration of function.”
The Business Unit leaders are as follows:
- Seth Brusseau, Vice President, Craniomaxillofacial (CMF)
- Rachel Edwards, Vice President, Foot & Ankle
- Milton Torres, Vice President, Hand & Upper Extremities
The leader for the Tendon, Ligament, and Biologics business unit will be named at a later date.
“The Acumed | OsteoMed BU leaders bring more than 50 years of orthopaedic experience to our combined organization,” said Chris Smith, President of Colson Medical. “I’m excited by how our leadership team, led by Sharon Wolfington, will benefit patients, healthcare providers, and healthcare facilities.”
Acumed | OsteoMed serves highly skilled specialized surgeons that demand comprehensive, high quality medical devices for patients with simple to complex injuries for optimal restoration of function.